Patent · US Active

Immunostimulatory anti-CEACAM1 antibody

US10106608B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

UNIVERSITÄT DUISBURG-ESSEN · DE

Inventors

Karl Lang · Essen, DE
Bernhard Singer · Essen, DE
Vishal Khairnar · Essen, DE
Vikas Duhan · Essen, DE
Fan Steven Zhou · Essen, DE

Key dates

Filing date	Jul 28, 2016
Grant date	Oct 23, 2018
Priority date	—
Expiry date	Jul 28, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An anti-CEACAM1 antibody includes at least one antibody heavy chain (VH) domain having antigen binding sites CDR1H, CDR2H and CDR3H, and at least one antibody light chain (VL) domain having antigen binding sites CDR1L, CDR2L and CDR3L. The antigen binding site CDR2H has a sequence homology of at least 80% to the amino acid sequence WINTYTGEPT (SEQ ID No. 21).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.